PTC Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of orally administered and small-molecule drugs. It offers Ataluren, an orally administered small-molecule investigational new drug for the treatment of cystic fibrosis and duchenne muscular dystrophy caused by nonsense mutations. The company also provides PTC299, an anti-angiogenesis drug for the treatment of metastatic breast cancer, multiple tumors, and neurofibromatosis. Its products are used for the treatment of genetic disorders, oncology, and infectious diseases. PTC Therapeutics, Inc. was founded in 1998 and is based in South Plainfield, New Jersey.

Saier Ruicheng (Beijing) Life Science Technology Co., Ltd., established on 2018-09-17, Business scope includes technology promotion,Technical Services,technical consulting,technology development,technology transfer;Import and export,Technology Import and Export,Agent import and export;Sales of biological reagents(Does not contain drugs,Free of Hazardous Chemicals),cosmetic,Instrumentation,Equipment,medical instrumentsIkind,Chemical Products(Free of Hazardous Chemicals);Economic and Trade Consulting,Business Management Consulting,buisness planning(No intermediary services);market survey;Conference Services;Undertake exhibition and display activities.(Market entities independently choose business projects in accordance with the law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Puri Benchmark Biomedicine (Suzhou) Co., Ltd., established on 2018-09-14, Business scope includes biomedicine,R&D of medical devices,Production,Sales;biotechnology development,technical consulting,technology transfer,Technical Services;laboratory consumables,experimental reagent(Does not contain hazardous chemicals),Instrumentation(No measuring vessel),Sales of computer software, hardware and auxiliary equipment;Engage in the import and export of the above commodities and technologies(Except for commodities and technologies that the state restricts enterprises to operate or prohibits import and export).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Shanghai Unicar-Therapy Bio-medicine Technology Co., Ltd. is a company headquartered in Songjiang, China. The firm provides cancer treatment services.

Kunyu Biotechnology (Jiangmen) Co., Ltd., established on 2019-12-06, The scope of business includes biotechnology services;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Production,Sales:First,two,Class III Medical Devices;Certification Information Consulting Service;road general freight;Domestic Freight Forwarder;Medical equipment rental;Import and export of goods or technology(Except for the import and export of goods and technologies that are prohibited by the state or involve administrative approval),Import and export agency.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Dongguk University Industry-Academic Cooperation Foundation is for the promotion of tenants and entrepreneurship.

CRISPR Therapeutics AG is a gene editing company, which engages in the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. Its CRISPR/Cas9 platform is a gene editing technology that allows for precise, directed changes to genomic DNA. The firm offers a portfolio of therapeutic programs across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine, and rare diseases. The company was founded by Rodger Novak, Emmanuelle Charpentier, Shaun Patrick Foy, Matthew Porteus, Daniel Anderson, Chad Cowan, and Craig Mellow on October 31, 2013 and is headquartered in Zug, Switzerland.

Oncocross Co. Ltd. Engages in Biopharmaceutical research services. The company was founded in July 2015 and is headquartered in Seoul, South Korea.

Beijing Pukang Ruiren Medical Laboratory Co., Ltd., established on 2015-11-27, Business scope includes medical laboratory services;technical consulting,technology development,Technical Services,technology transfer;Sales of laboratory instruments,Laboratory Chemical Reagents(Free of Hazardous Chemicals),Computer hardware and software and peripheral equipment(Excluding special products for computer information system security);Import and export,Technology Import and Export,Agent import and export.(Market entities independently choose business projects in accordance with the law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Bayer HealthCare Ltd., established on 1995-08-25, Business scope includes licensed projects:pharmaceutical production;Pharmaceutical commissioned production;Drug Wholesale;Drug import and export;Production of Class II Medical Devices;Production of Class III Medical Devices;Class III medical device business;food sales;Health food production;food production;Production of formula food for special medical purpose;Cosmetic production;Production of hygiene products and single-use medical products;Disinfectant production(Free of Hazardous Chemicals).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Medical Research and Experimental Development;Production of Class I Medical Devices;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Cosmetics Wholesale;Cosmetics Retail;internet sales(Except for products that require a license for sale);Food import and export;software development;software sales;Retailing of computer software, hardware and auxiliary equipment;Wholesale of computer software, hardware and auxiliary equipment;Manufacturing of computer software, hardware and peripheral equipment;Software outsourcing service;Information Consulting Service(Not including licensing information consulting services);Information Technology Consulting Services;Special Equipment Repair;Import and export;Technology Import and Export;Import and export agency;Sales of hygiene products and single-use medical products;Disinfectant sales(Free of Hazardous Chemicals);Manufacturing of daily chemical products;Sales of daily chemical products.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)(Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Precision Scientific provides drug mechanism research services for pharmaceutical and biotechnology companies. The company's self-developed cutting-edge AI technology ALBERT (AI-driven Big data analytics for Effective Response of cancer Therapy) is a machine learning-based analysis of multi-omics data using data mining and predictive algorithms to provide solutions for oncology research, including drug target discovery, biomarker identification, indication selection, drug resistance mechanism evaluation, and combo therapy strategy.

The Rural Development Administration (Korean: 농촌진흥청; Hanja: 農村振興廳, RDA) is one of an agriculture organizations in South Korea and is run under the Ministry of Agriculture, Food and Rural Affairs. The headquarters are in Wansan-gu, Jeonju.

Genetron Health is a world-leading expert in precision medicine.They are committed to developing health management products that cover all elements of full-cycle cancer clinical treatment (including risk assessment, early screening, molecular pathology diagnosis, medication guidance and prognosis monitoring) and effectively applying genomic data to assist medical experts and research scientists. Additionally, they provide cancer patients and high-risk and healthy individuals with reliable molecular clinical services and professional cancer genetic risk assessment.In just three years, Genetron Health has built global genomics sequencing and bioinformatics platforms, established two research and development centers in both North Carolina, U.S., and Beijing, China, and set up clinical laboratories in Beijing, Shanghai, Hangzhou and Chongqing of over 10,000 square meters.In the future, Genetron Health will spread its sales network throughout China with professional marketing, product management, medical experts and scientific research teams, and will provide service for Chinese and global cancer patients with its strong foundation in cancer genomics and efficient clinical translation.

Hulunbuir Northeast Fufeng Biotechnology Co., Ltd., established on 2010-05-14, Business scope includes food production;food sales;fertilizer production;Feed additive production;feed production;Food additive production;fertilizer sales;Fertilizer sales;Sales of agricultural and sideline products;Feed Additive Sales;Feed Raw Material Sales;Food Additive Sales;Non-residential real estate leases;Coal and product sales;container maintenance;Loading and unloading;Container Leasing Service;Domestic Freight Forwarding

Massachusetts General Hospital was established to provide care to Boston's sick, regardless of socioeconomic status—an innovative idea in 1811. In the words of their founder, John Warren, MD, “When in distress, every man becomes their neighbor.” They subsequently became the first teaching hospital for Harvard University’s new medical school and have been redefining excellence in healthcare ever since. They have remained at the forefront of medicine by fostering a culture of collaboration, pushing the boundaries of medical research, educating the brightest medical minds and maintaining an unwavering commitment to the diverse community they were created to serve. They believe that because of diversity they excel, through inclusion they respect their community, and with a keen focus on equity they serve, heal, educate and innovate at the highest levels. Their first priority is the well-being of their patients—near and far. As a team they are able to maintain a singular focus on providing the highest quality, most compassionate care to each and every patient.

The Eli and Edythe L. Broad Institute of MIT and Harvard (/ˈbroʊd/), often referred to as the Broad Institute, is a biomedical and genomic research center located in Cambridge, Massachusetts, United States. The institute is independently governed and supported as a 501(c)(3) nonprofit research organization under the name Broad Institute Inc., and is partners with Massachusetts Institute of Technology, Harvard University, and the five Harvard teaching hospitals.

UAB Research Foundation (doing business as UABRF), a subsidiary of The University of Alabama System, is a company headquartered in Birmingham, AL. The firm engages in identify, assess, and market commercially viable technology developed at The University of Alabama at Birmingham.